Clinical Trials | July 27, 2022
Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
The product will be manufactured at Lupin's facility in Nagpur, India.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Better serving global partners and advancing healthcare innovation
Merck’s first microbiology application and training lab in India
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Subscribe To Our Newsletter & Stay Updated
